Undisclosed Kv1.3 blocker / Muna Therap - LARVOL DELTA

Muna Therapeutics Awarded $4.9M Grant from The Michael J. Fox Foundation for Parkinson's Research (PRNewswire) - "Muna Therapeutics...announced today that it has been awarded a $4.9 million grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF). The grant will be used to support ongoing preclinical research and development of novel, brain-exposed, small molecule potassium channel type 1.3 (Kv1.3) blockers to abrogate neuroinflammation driven by disease-associated microglia and enhance neuroprotection as a disease-modifying therapy for patients with Parkinson's disease....The grant from MJFF will support work at Muna Therapeutics and in collaboration with Professor Bart De Strooper at VIB/KU Leuven, a scientific co-founder of Muna, for two years."

Financing • CNS Disorders • Parkinson's Disease